Systemic bioactivity profiles of oral prednisolone and nebulised budesonide in adult asthmatics

Andrew M. Wilson, Lesley C. McFarlane, Brian J. Lipworth

Research output: Contribution to journalArticle

35 Citations (Scopus)


Because nebulized budesonide may be used as an alternative to maintenance oral prednisolone in the treatment of severe chronic asthma, it is important to compare these two drugs to determine their relative systemic bioactivity profiles in terms of effects on adrenal, bone, and hematologic markers.
Original languageEnglish
Pages (from-to)1022-1027
Number of pages6
Publication statusPublished - 1998

Cite this